Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine-Reference-Cited by-同舟云学术

Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine

Published:2009-03 Issue:2 Volume:29 Page:119-122
ISSN:0256-4947
Container-title:Annals of Saudi Medicine
language:en
Short-container-title:Annals of Saudi Medicine

Author:

Sweileh Waleed M.¹,Sawalha Ansam F.²,Rinno Tamara M.¹,Zyoud Sa'ed H.²,Al-Jabi Samah W.¹

Affiliation:

1. College of Pharmacy, An-Najah National University, Nablus, Palestine

2. Poison Control and Drug Information Center (PCDIC), An-Najah National University, Nablus, Palestine

Publisher

King Faisal Specialist Hospital and Research Centre

Subject

General Medicine

Reference16 articles.

1. Longterm trends in the incidence of and survival with heart failure;Levy D;N Engl J Med,2002

2. Rahko et al ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Managemment of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society;Hunt SA;Circulation,2005

3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group;N Engl J Med,1987

4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators;N Engl J Med,1991

5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE Investigators;Pfeffer MA;N Engl J Med,1992

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia;VASC HEALTH RISK MAN;2022

2. Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia;BioMed Research International;2019-04-24

3. Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study;BMC Research Notes;2018-03-28